Pamela H. Chin

Pamela Chin practices at Emanuel Medical Center in Turlock, California, part of Tenet Healthcare.

Pamela Chin's NPI, 1942720180, was assigned on June 20, 2017. Pamela Chin holds Arizona license 60358.

Pamela Chin's primary practice is Emanuel Medical Center, at 825 Delbon Ave, Turlock, CA 95382 in Stanislaus County. The practice phone is (209) 667-4200.

Pamela Chin's primary practice is Emanuel Medical Center in Turlock, California, part of Tenet Healthcare. Pamela Chin is also affiliated with Sharp Grossmont Hospital. The medical group on file is Vituity. Dmand AI also links Pamela Chin to 3 more hospitals, 8 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Pamela Chin practices, 7 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Pamela Chin's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Pamela Chin's licenses on file in 7 states: Arizona, California, Florida, Illinois, Indiana, Pennsylvania and Wisconsin.

CMS data shows 307 Medicare services from Pamela Chin across 4 procedure codes in 2024, for 195 Medicare patients. Medicare paid $23,646 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 195 Medicare patients who saw Pamela Chin in 2024. The largest group is 75 to 84, with 70 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 41% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Pamela Chin's median patient age at 40, with 58% women.

In 2024, Pamela Chin wrote 185 Medicare Part D claims for 116 patients. 96% of them were for generic drugs. CMS names the drug for 80 of them, across 5 drugs with 11 or more claims each, at $370 in total drug cost. In 2023, CMS named 92 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Pamela Chin for performance year 2024, reported as part of a group. Pamela Chin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Pamela Chin from 3 drug and device companies from 2023 to 2024. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $33.